On April 4, 2024 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that management will participate in the following investor conferences in April (Press release, ORIC Pharmaceuticals, APR 4, 2024, View Source [SID1234641786]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

23rd Annual Needham Virtual Healthcare Conference – Presenting a company overview on Thursday, April 11, 2024, at 3:45 p.m. ET
Stifel Virtual Targeted Oncology Forum – Participating in a virtual fireside chat on Wednesday, April 17, 2024, at 12:30 p.m. ET.
Webcasts of the presentation and discussion will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the events.